Overview Financials News + Filings Key Docs Charts Ownership Insiders |
|
KINETA, INC. (PTI)
|
Add to portfolio |
|
|
|
| Price: |
$2.97
| | Metrics |
| OS: |
9.77
|
M
| |
-159
|
% ROE
|
| Market cap: |
$29
|
M
| |
-1320
|
% ROIC
|
|
Net cash:
|
$7.01
|
M
| |
$0.72
|
per share
|
|
EV:
|
$22
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($14.9)
|
M
| |
|
|
| EPS |
($1.47)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 2.0 | 17.0 | 9.1 | 23.4 | 6.9 | 0.0 | 2.8 | 5.3 |
| Revenue growth | -78.5% | -27.6% | 31.8% | | | -100.0% | -46.8% | -36.3% |
| Cost of goods sold | 0.0 | 30.9 | 0.0 | 29.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 2.0 | -14.0 | 9.1 | -6.5 | 6.9 | 0.0 | 2.8 | 5.3 |
| Gross margin | 100.0% | -82.4% | 100.0% | -27.6% | 100.0% | | 100.0% | 100.0% |
| Selling, general and administrative | 43.5 | | 20.2 | | | | | |
| Research and development | | | | | 22.3 | 23.0 | 50.3 | 53.7 |
| General and administrative | | 8.7 | | 4.6 | 11.9 | 7.1 | 15.7 | 11.7 |
| EBIT | -85.3 | -22.7 | -12.5 | -11.1 | -55.6 | -30.0 | -63.2 | -60.0 |
| EBIT margin | -4369.2% | -133.6% | -137.9% | -47.3% | -806.7% | | -2224.7% | -1122.9% |
| Pre-tax income | -63.4 | -63.4 | -11.8 | -11.8 | -57.5 | -31.2 | -61.8 | -59.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -63.4 | -63.4 | -11.8 | -11.8 | -50.8 | -31.2 | -61.8 | -59.4 |
| Net margin | -3246.7% | -373.7% | -130.0% | -50.4% | -736.5% | | -2177.2% | -1112.8% |
| |
| Diluted EPS | ($12.87) | ($12.87) | ($2.71) | ($2.71) | ($21.57) | ($14.71) | ($1.61) | ($2.34) |
| Shares outstanding (diluted) | 4.9 | 4.9 | 4.4 | 4.4 | 2.4 | 2.1 | 38.5 | 25.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|